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Abstract
The Infection Prevention and Control team at Rotherham 
Foundation Trust made the decision to switch from saline 
solution to an antimicrobial solution for skin cleansing 
prior to urinary catheterisation. The first stage of the 
switch has taken place in the community, with secondary 
care likely to follow suit at a later stage. The rationale for 
the switch, the two year journey it took to implement the 
changes and the parameters by which the success of the 
switch will be evaluated, are discussed in this article.
Catheter-associated urinary tract infections (CAUTI) 
are a cause of considerable concern and any measures 
which can be taken to potentially reduce the rate of 
CAUTI’s should be given careful consideration. In 2012 
the Infection Prevention and Control team at Rotherham 
Foundation Trust switched from saline solution to an 
antimicrobial solution (Octenilin® cleaning solution 
sachets) for skin cleansing prior to urinary catheterisation 
to try to reduce CAUTI’s. Initially, Octenilin cleansing 
solution sachets were intended for use solely for patients 
with a current or historical confirmed result of MRSA 
in the urine and/or other sites. However, use has been 
extended to other patients, including those with a history 
of E. coli or Klebsiella, Gram-negative organisms 
frequently identified as a source of UTI’s. Early feedback 
from using Octenilin cleansing solution sachets in place 
of saline solution has indicated a high level of satisfaction 
from both patients and health-care professionals. Reports 
of catheterisation-associated trauma have reduced 
significantly and no CAUTI’s have been identified to date.
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INTRODUCTION
Urinary catheterisation is a key aspect of patient care. 
A prevalence study from the Hospital Infection Society 
estimates that around 32% of patients in hospital have a 
urinary catheter (Hospital Infection Society 2007). In the 
acute setting, urinary catheterisation is likely to be on a 
short-term basis (less than 14 days).
In the community, long-term urinary catheterisation 
(i.e. longer than 28 days) is estimated to be used in 
the management of around 4% of patients undergoing 
domiciliary care (Nation Institute of Health and Care 
Excellence (NICE) 2003). Long-term catheterisation of 
the bladder is often used in the care of older patients and 
those with neurological conditions. Patients with urinary 
retention or urinary incontinence may require continuous 
bladder drainage using a urethral or suprapubic catheter.
Indwelling catheters place patients at significant risk of 
acquiring a urinary tract infection. It is estimated that 19% 
of all health-care associated infections are urinary tract 
infections (Loveday et al, 2014) and catheter-associated 
urinary tract infections (CAUTIs) account for between 
43% and 56% of these infections (Loveday et al, 2014).
The longer a catheter is in place, the greater the 
likelihood of a urinary tract infection developing. In the 
acute setting, 20-30% of catheterised patients develop 
bacteriuria, with the risk increasing by approximately 5% 
for each day of catheterisation (Loveday et al, 2013). A 
US study demonstrated that the use of indwelling urinary 
catheters was associated with higher colonisation rates of 
methicillin-resistant Staphylococcus aureus (MRSA). Of 
the 51 nursing home residents in the study who had an 
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indwelling catheter, 28 (55%) were colonised with MRSA 
at any site. Residents who had urinary catheters were 2.8 
times as likely to be colonised with MRSA as those in the 
control group without a urinary catheter (Mody 2007).
The patient’s own colonic flora are likely to be the 
cause of most infections, as the urethral catheter provides 
a direct entry point for bacteria into the bladder. When 
the bacteria attach to the surface of the catheter, they may 
mutate into biofilms.
Urinary  t rac t  infec t ions ,  t i ssue  damage and 
encrustation of the catheter (which may block the 
catheter) are all complications that can arise during long-
term catheterisation. It is important to provide effective 
catheter care to minimise the risk of complications. 
There continues to be debate about certain aspects of 
catheter management, including skin cleansing prior to 
catheterisation.
1.  GUIDELINES FOR SKIN CLEANING 
BEFORE URINARY CATHETERISATION
The Guidance for Prevention of Catheter-Associated 
Urinary Tract Infections (Healthcare Infection Control 
Practices Advisory Committee (HICPAC), 2009) 
recommends that as aseptic technique and sterile 
equipment are essential.  However, the guidance 
state that ‘further research is needed on the use of 
antiseptic solutions versus sterile water or saline for 
periurethral cleaning prior to catheter insertion’. No 
recommendation is made in terms of using an antiseptic 
or saline solution. NICE (2012) recommends that ‘for 
urethral catheterisation, the meatus should be cleaned 
before insertion of the catheter, in accordance with local 
guidelines/policy’. NICE does not give specific guidance 
regarding the use of particular cleansing agents.
2.  BACKGROUND
Around 1200 mainly elderly patients are cared for by the 
Rotherham NHS Foundation Trust Community Continence 
service. This includes patients who intermittently perform 
self-catheterisation and 477 patients with a long term 
urethral or supra pubic catheter. Re-catheterisation takes 
place at least every 12 weeks and patients likely to be at 
high risk of infection are identified and closely monitored. 
All patients are screened for MRSA in the urine prior to 
catheterisation. 
Reducing and eliminating infections is a high priority 
for the trust and MRSA remains a key quality indicator. 
The trust has adopted the NHS Safety Thermometer as a 
template to identify where improvements can be made and 
take appropriate action. The NHS Safety Thermometer 
identifies CAUTI as a key patient harm (Department of 
Health 2012) and the trust has taken measures to focus on 
the prevention of CAUTIs.
3.  SELECTING AN ANTIMICROBIAL 
SOLUTION
In 2012, in the absence of any definitive guidelines and 
based on the Infection Prevention and Control team and 
the Continence teams’ experience of using antimicrobial 
solutions, it was agreed to use an antimicrobial solution 
rather than saline solution to clean the meatus prior to 
urinary catheterisation.
The antimicrobial selected needed to:
• Have a broad antimicrobial efficacy
• Be non-irritating to the skin
• Be available in a single use presentation
• Cost a similar amount to saline solution
Octenilin® cleaning solution sachets (an octenidine 
based antimicrobial solution) were chosen on the basis of 
the Community Infection Prevention and Control team’s 
previous positive experience of using Octenisan® wash 
lotion (also an octenidine based solution).
Initially, Octenilin® cleaning solution sachets were 
intended for use solely for patients with a current or 
historical confirmed result of MRSA in the urine and/
or other sites. However, the use has been extended to 
other patients, including those with a history of E. coli or 
klebsiella , which are gram negative organisms frequently 
identified as a source of urinary tract infections (UTIs). 
Octenilin®cleansining solution was also used for patients 
identified with recurrent UTIs or UTI-like symptoms after 
catheterisation.
4.  OCTENILIN® CLEANING SOLUTION 
Octenilin® cleaning solution 30ml sachets contain an 
octenidine-based antimicrobial solution for the cleaning 
and decontamination of skin before urinary catheterisation. 
The cleaning solution consists of a combination of 
octenidine and ethylhexylglycerin. Ethylhexylglycerin 
reduces the surface tension of the skin. 
Octenidine® is a broad-spectrum antimicrobial that 
is active against Staphylococcus aureus, Staphylococcus 
epidermidis, Proteus mirabilis, Streptococcus pyogenes, 
Klebsiella pneumoniae, Escherichia coli, Pseudomonas 
aeruginosa, Serratia marcescens and Candida albicans. 
Research has shown that octenidine reduces levels 
of resident skin bacteria by between 90.00% and 
99.98%, depending on the concentration and number of 
applications [Sedlock and Bailey 1985].
It is known that, once attached to the catheter 
surface, bacteria change and form microcolonies and 
eventually mature into biofilms [Jacobsen, 2008]. Studies 
have demonstrated that octenidine dihydrochloride is 
effective in preventing the formation of Staphylococcus 
aureus biofilms and can also help remove established 
Staphylococcus aureus biofilms [Westgate and Cutting, 
2012].
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A study undertaken in an independent laboratory 
compared skin cleansing using saline solution with an 
octenidine based antimicrobial solution. The octenidine 
based solution had superior bacterial reduction properties, 
removing 90% of a known bacterial population of E. coli 
from the surface of the skin. The reduction with saline 
solution was 55%. The solution was left in contact with 
the skin for two minutes. [Sandle, 2013].
5.  MAKING THE SWITCH FROM SALINE 
TO AN ANTIMICROBIAL SOLUTION
The project—from considering Octenilin® cleaning 
solution sachets as a theoretical concept for cleansing prior 
to urinary catheterisation to actually using the product in 
practice—has taken 2 years. Their use in the community 
is now well established and the next aim is to introduce 
the sachets into secondary care. The Continence team 
working in primary care has good links to the Community 
Infection Prevention and Control team. This was a 
significant benefit when first introducing the concept of 
switching to an antimicrobial wash. The Continence team 
were already familiar with Octeniasan® wash lotion, 
which has the same active ingredient (octenidine) as the 
Octenilin® sachets. This familiarity helped as the team 
were confident to use the product and found it to be gentle 
and non-irritating to the skin.
However, before the team could start using Octenilin® 
cleaning solution there were extensive discussions with 
the Medicines Management team about including octenilin 
solution on the Formulary. Clinical data were presented to 
the Hospital Chief Pharmacist. The implications in terms 
of cost and staff time were taken into consideration. A 
business case was developed which included the cost of 
preventing one CAUTI compared to the cost of treating a 
CAUTI. 
The switch was cost-neutral, as three 5ml pods of 
saline solution cost around 60p and one 30ml sachet of 
octenilin cleaning solution costs in the region of 55p. The 
business evidence was overwhelming in favour of the 
change, and once the switch had been made would not 
affect staff time.
The simplest and most cost effective mechanism was 
for the Trust to purchase Octenilin solution directly from 
the supplier rather than pharmacy, to distribute to the 
Continence team. Otherwise prescribing costs of £7.65 
per patient would have been incurred, which would have 
made the change prohibitive. The Continence budget is 
held by the Continence team (not the GPs) which made 
the process simpler to implement.
A new catheterisation protocol which included the 
use of Octenilin® cleaning solution for cleansing prior 
to urinary catheterisation was drawn up for use in the 
community, by the Community Infection Prevention 
and Control team. The protocol advises that Octenilin® 
cleaning solution should be applied undiluted to the skin, 
ensuring that the area to be cleansed is completely covered 
with the Octenilin® solution. It is left on the skin for 1 - 
2 minutes before continuing with the catheter insertion 
procedure. 
6.  BENCHMARKING
In order to provide a benchmark by which to measure the 
use of Octenilin® solution, all patients with an indwelling 
urethral or supra pubic catheter were screened for MRSA 
in the urine before catheterisation and before the use 
of Octenilin® solution. Of the 477 patients with a long 
term urethral or supra pubic catheter 22 were found to be 
colonised with MRSA on their skin but with no signs of 
clinical or systemic infection. Six patients out of the 22 
had a history of a positive result for MRSA in the urine. It 
is unclear if the MRSA was present prior to or whether it 
developed after catheterisation.
All of the patients are screened (nose, groin and urine 
as standard) prior to re-catheterisation and the results 
determine the response. Any patient who is positive for 
MRSA is decolonised with Octenisan® wash lotion if 
appropriate and those with MRSA in the urine who test 
positive prior to catheterisation may be considered for 
antibiotic treatment. 
The Continence team works with the Infection 
Prevention and Control team to identify low- and high risk 
patients. Low risk patients with a catheter are those who 
are re-catheterised 12 weekly or less, who do not have 
issues with the procedure and have not developed a UTI. 
The high risk group are those patients who require more 
frequent catheterisation due to blockage, UTI, those with 
a history of MRSA or other infection (E. coli, Klebsiella 
or pseudomonas) and those who experience trauma or 
difficult catheterisations. 
Once the protocol was finalised and supplies 
of Octenilin® solution purchased, the switch was 
communicated to the Continence team by email. All 
feedback received was highly positive about the change. 
7.  EVALUATION
After twelve months, the community data will be analysed 
looking at MRSA in the urine and at the catheter site. The 
optimum outcome will be either a status quo on the current 
numbers of MRSA bacteria in the urine or a reduction in 
the number of positive MRSA bacteria in the urine. Rates 
of E. coli and Klebsiella will also be monitored in patients 
known to be susceptible to infection with these organisms. 
Early results have been promising as these patients have 
not developed the usual UTI issues post-catheterisation. 
This is not a randomised controlled trial, but will be an 
evaluation of feedback and date obtained.
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7.1  Case Study 1
Bert is 82, lives alone and has urinary incontinence. To 
help manage this, Bert has a long-term catheter which 
is monitored regularly by the district nursing team. Bert 
has a very tight foreskin which makes the catheterisation 
procedure traumatic, but he has declined surgery to rectify 
the problem. During the 3 years that Bert has had the long-
term catheter, he has had recurrent Klebsiella infections 
in his urine. In spite of repeated courses of antibiotics, the 
infections have been difficult to treat. His urine was often 
thick and cloudy, leading to blockage of the catheter and 
the need for frequent catheter changes.
It was agreed to start using Octenilin® cleaning 
solution sachets rather than saline solution for cleansing 
prior to catheterisation. Octenilin® cleaning solution was 
also used in place of saline to soften the foreskin area 
to help make the procedure easier for Bert. Octenilin® 
cleaning solution has now been used for 4 months prior 
to re-catheterisation. To date Bert has not had a CAUTI 
or experienced his usual post-catheterisation trauma 
symptoms of blood in the urine and feeling unwell. He 
claimed: 
I used to dread having the catheter changed; it was really painful 
and made me feel ill afterwards. It’s much easier now the nurses 
are using a different cleaner.
7.2  Case Study 2
Margaret is an 86-year-old female living with her 
husband. She has had multiple sclerosis for 20 years. 
Her condition is deteriorating; she has no mobility and is 
doubly incontinent. Her husband is supported by a team 
of care workers, including the Continence team. Margaret 
has had a long-term urethral catheter for the past 10 years, 
which is changed every 12 weeks. She has a long history 
of MRSA colonisation, including MRSA in her urine and 
frequent UTIs (which have, on occasion, necessitated 
emergency hospital admission).
Since switching from saline solution to Octenilin® 
cleaning solution sachets for pre-catheterisation skin 
cleansing Margaret has tested negative for MRSA in her 
urine for 8 months and has not required any antibiotics 
or unplanned hospital admissions. The single-use 
Octenilin® cleaning solution sachets are easy to use and 
the Continence team are looking to extend their usage to 
all patients with a long-term urinary catheter.
7.3  Case Study 3
Jason is a 24-year-old male and was involved in a 
catastrophic road traffic accident 6 years ago. The 
accident left him with a severe traumatic brain injury and 
very little sensation from the neck downwards. He has a 
level of cognition and lives in a converted house next door 
to his parents, supported by 24-hour care.
Jason is doubly incontinent and has no bladder control. 
He has had a long-term suprapubic catheter in situ since 
his accident. This is changed every 4 weeks by the 
Continence team. Jason has had recurrent UTIs, usually 
caused by E. coli, Klebsiella and other non-specific 
organisms. He also has post-catheterisation trauma, 
including haematuria. Jason is colonised with MRSA in 
his groin and nose; he has frequently tested positive for 
MRSA in his urine, despite undergoing decolonisation 
procedures and the prescription of antibiotics. He is 
categorised as a high-risk patient for developing a 
bacteraemia.
Octenilin® cleaning solution sachets have been 
used instead of saline solution for 7 months for pre-
catheterisation skin cleansing. During this time Jason has 
not tested positive for MRSA and has not contracted a 
CAUTI.
A nurse in the Continence team that regularly monitors 
Jason said:
I can’t believe the difference this has made. I didn’t think Jason 
would be free of infection for as long as this. Ideally I would 
use Octenilin® cleaning solution for pre-catheterisation skin 
cleansing for all of my patients.
CONCLUSION
The Rotherham NHS Foundation Trust Community 
Division pioneered the use of Octenilin® cleaning solution 
sachets for skin cleansing prior to urinary catheterisation. 
Using an antimicrobial wash rather than saline solution 
has so far demonstrated promising results in terms of 
preventing CAUTIs and catheter-associated trauma. 
The switch was cost-neutral. An ongoing evaluation is 
being conducted by the Continence team and further data 
about the efficacy of using an antimicrobial wash will be 
available after 12 months of use.
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